From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward.
GLP-1 receptor agonists may treat substance use disorders through reward-system mechanisms, beyond their known obesity and diabetes benefits.
This Biological Psychiatry review synthesizes neural mechanisms by which GLP-1 signaling bridges appetite regulation and reward circuitry, with implications for substance use disorders. The authors argue GLP-1 receptor agonists may have therapeutic utility for addiction beyond obesity/diabetes, based on converging preclinical and emerging clinical evidence.
What the study was
- Study design
- Narrative review
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Biological Psychiatry
Why it surfaced
Biological Psychiatry high-impact review; GLP-1 in substance use disorder is a rapidly emerging area with major clinical implications; expands GLP-1 watchlist coverage to psychiatric applications.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.